Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note issued to investors on Sunday morning. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 target price on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Stock Performance

Shares of AEMD opened at $0.40 on Friday. The stock has a 50 day moving average price of $0.40 and a 200 day moving average price of $0.43. Aethlon Medical has a one year low of $0.24 and a one year high of $2.35. The stock has a market capitalization of $5.52 million, a price-to-earnings ratio of -0.14 and a beta of 1.74.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.